Literature DB >> 31181585

Pre-eclampsia/Eclampsia.

José Carlos Peraçoli1, Vera Therezinha Medeiros Borges1, José Geraldo Lopes Ramos2, Ricardo de Carvalho Cavalli3, Sérgio Hofmeister de Almeida Martins Costa2, Leandro Gustavo de Oliveira1, Francisco Lazaro Pereira de Souza4, Henri Augusto Korkes5, Ione Rodrigues Brum6, Maria Laura Costa7, Mário Dias Corrêa Junior8, Nelson Sass9, Angélica Lemos Debs Diniz10, Caio Antonio de Campos Prado3, Edson Viera da Cunha Filho11.   

Abstract

Pre-eclampsia is a multifactorial and multisystemic disease specific to gestation. It is classically diagnosed by the presence of hypertension associated with proteinuria manifested in a previously normotensive pregnant woman after the 20th week of gestation. Pre-eclampsia is also considered in the absence of proteinuria if there is target organ damage. The present review takes a general approach focused on aspects of practical interest in the clinical and obstetric care of these women. Thus, it explores the still unknown etiology, current aspects of pathophysiology and of the diagnosis, the approach to disease prediction, its adverse outcomes and prevention. Management is based on general principles, on nonpharmacological and on pharmacological clinical treatment of severe or nonsevere situations with emphasis on the hypertensive crisis and eclampsia. Obstetric management is based on preeclampsia without or with signs of clinical and/or laboratory deterioration, stratification of gestational age in < 24 weeks, between 24 and less than 34 weeks, and ≥ 34 weeks of gestation, and guidance on route of delivery. An immediate puerperium approach and repercussions in the future life of pregnant women who develop preeclampsia is also presented. Thieme Publicações Ltda Rio de Janeiro, Brazil.

Entities:  

Mesh:

Year:  2019        PMID: 31181585     DOI: 10.1055/s-0039-1687859

Source DB:  PubMed          Journal:  Rev Bras Ginecol Obstet        ISSN: 0100-7203


  6 in total

Review 1.  Analyzing Preeclampsia as the Tip of the Iceberg Represented by Women with Long-Term Cardiovascular Disease, Atherosclerosis, and Inflammation.

Authors:  Angélica Lemos Debs Diniz; Maria Marta Bini Martins Paes; Aline Debs Diniz
Journal:  Curr Atheroscler Rep       Date:  2020-02-19       Impact factor: 5.113

Review 2.  Foetal lipoprotein oxidation and preeclampsia.

Authors:  L A Gil-Acevedo; Guillermo Ceballos; Y D Torres-Ramos
Journal:  Lipids Health Dis       Date:  2022-06-04       Impact factor: 4.315

3.  The WHO Safe Childbirth Checklist implementation: impact on the prescription of magnesium sulphate through a one-year longitudinal study.

Authors:  Zenewton André da Silva Gama; Wilton Rodrigues Medeiros; Pedro Jesus Saturno-Hernández; Kelienny de Meneses Sousa; Matheus Silva Mello; Érico de Lima Vale; Tatyana Maria Silva de Souza Rosendo; Edna Marta Mendes da Silva; Marise Reis de Freitas
Journal:  BMC Pregnancy Childbirth       Date:  2020-03-12       Impact factor: 3.007

4.  Geographical access to point-of-care testing for hypertensive disorders of pregnancy as an integral part of maternal healthcare in Ghana.

Authors:  Desmond Kuupiel; Kwame Manu Adu; Vitalis Bawontuo; Philip T N Tabong; Duncan A Adogboba; Tivani P Mashamba-Thompson
Journal:  BMC Pregnancy Childbirth       Date:  2020-11-25       Impact factor: 3.007

5.  Uterine vascular resistance and other maternal factors associated with the risk of developing hypertension during pregnancy.

Authors:  L A B Martins; E C A Veiga; C C C Ribeiro; V M F Simões; V C Cardoso; H Bettiol; M A Barbieri; R C Cavalli
Journal:  Braz J Med Biol Res       Date:  2020-11-18       Impact factor: 2.590

Review 6.  Eclampsia and Its Treatment Modalities: A Review Article.

Authors:  Shivani Akre; Kapil Sharma; Swarupa Chakole; Mayur B Wanjari
Journal:  Cureus       Date:  2022-09-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.